NYSE · NVSTHealthcareDental Equipment

Envista Holdings Corporation Common stock, $0.01 par value per share financials

$23.33−1.69%
Close Sep 29, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

Fiscal yearFY25
Dec 31
FY24
Dec 31
FY23
Dec 31
FY22
Dec 31
FY21
Dec 31
FY20
Dec 31
FY19
Dec 31
Revenue$2.72B$2.51B$2.57B$2.57B$2.51B$1.93B$2.28B
Gross profit$1.49B$1.37B$1.44B$1.47B$1.43B$1.05B$1.35B
Gross margin54.7%54.7%56.1%57.4%56.9%54.7%59.1%
Operating income$216.1M-$1.04B$31.5M$319.2M$306.2M$43.5M$235.7M
Net income$47.0M-$1.12B-$100.2M$243.1M$340.5M$33.3M$217.6M
Net margin1.7%−44.6%−3.9%9.5%13.6%1.7%9.5%
Diluted EPS$0.28$-6.50$-0.60$1.37$1.92$0.20$1.60
EBITDA$332.1M$238.7M$425.4M$457.0M$458.1M$176.1M$364.2M
Operating cash flow$275.7M$336.5M$275.7M$182.7M$361.6M$283.9M$397.5M
Free cash flow$230.4M$302.7M$217.5M$107.0M$306.9M$236.2M$319.7M
Diluted shares169.2M172.2M166.9M177.6M177.6M164.1M136.4M

Balance sheet

Period endDec 31Dec 31Dec 31Dec 31Dec 31Dec 31
Cash & equivalents$1.21B$1.07B$940.0M$606.9M$1.07B$888.9M
Short-term investments$0.00$0.00$0.00$0.00——
Total debt$1.45B$1.39B$1.51B$1.38B$1.32B$1.79B
Total assets$5.68B$5.35B$6.61B$6.59B$6.57B$6.88B
Total liabilities$2.57B$2.42B$2.43B$2.38B$2.52B$3.15B
Shareholders' equity$3.11B$2.93B$4.17B$4.21B$4.06B$3.72B

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology